Tsubota Laboratory Incorporated (TYO:4890)
Japan · Delayed Price · Currency is JPY 277.00
-4.00 (-1.42%)
Aug 21, 2026, 3:30 PM JST
Tsubota Laboratory Revenue
Tsubota Laboratory had revenue of 215.41M JPY in the quarter ending June 30, 2026, with 766.73% growth. This brings the company's revenue in the last twelve months to 390.58M, down -71.20% year-over-year. In the fiscal year ending March 31, 2026, Tsubota Laboratory had annual revenue of 200.00M, down -85.26%.
Revenue (ttm)
390.58M
Revenue Growth
-71.20%
P/S Ratio
18.29
Revenue / Employee
n/a
Employees
22
Market Cap
7.15B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 200.00M | -1.16B | -85.26% |
| Mar 31, 2025 | 1.36B | 684.00M | 101.63% |
| Mar 31, 2024 | 673.00M | -281.00M | -29.45% |
| Mar 31, 2023 | 954.00M | 314.00M | 49.06% |
| Mar 31, 2022 | 640.00M | -47.00M | -6.84% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ain Holdings | 647.83B |
| Ohki Healthcare Holdings | 363.02B |
| Qol Holdings | 292.95B |
| YAKUODO HOLDINGS | 168.44B |
| Medical System Network | 134.23B |
| Satudora Holdings | 100.57B |
| Pharmarise Holdings | 69.51B |
| Astena Holdings | 67.21B |